Mazor Robotics' Renaissance(R) Guidance System Achieves New Clinical Milestone
Mar 01, 2016 13:23 pm UTC| Business
ORLANDO, Fla., March 1, 2016 -- Mazor Robotics (www.mazorrobotics.com), a pioneer in surgical guidance systems for spine and brain surgery, announced today a new clinical milestone with the successful completion of over...
ArcView Hires Top Talent & Launches Winner's Fund
Mar 01, 2016 13:20 pm UTC| Business
$50,000 to go to top rated companies at its pitch events Companies to receive more help before pitching OAKLAND, Calif., March 1, 2016 -- Today, The ArcView Group announced the launch of a Winner's Fund that will...
Michael Madon Joins VerifyMe as Chairman of the Board of Directors
Mar 01, 2016 13:15 pm UTC| Business
NEW YORK, March 01, 2016 -- VerifyMe, Inc. (OTCBB:VRME), a pioneer in patented physical, cyber and biometric technology solutions that prevent identity theft, counterfeiting and fraud, today announced that Michael Madon...
RedHill Biopharma Provides 2016 R&D Update
Mar 01, 2016 13:01 pm UTC| Business
RedHill’s advanced pipeline includes three Phase III programs, several Phase II programs and additional early-stage programs. RedHill maintains a strong and debt-free balance sheet, allowing the Company to continue to...
Mar 01, 2016 13:01 pm UTC| Business
ORLANDO, Fla., March 01, 2016 -- Medical Compression Systems, Inc. (MCS), a leader in the development of smart compression treatments that enhance arterial, venous and lymphatic circulation, today announced the...
UBIC to Launch “Lit i View SNS MONITORING” System for Government Agencies in Japan
Mar 01, 2016 13:00 pm UTC| Business
TOKYO, March 01, 2016 -- UBIC, Inc. (Nasdaq:UBIC) (TSE:2158) ("UBIC" or "the Company"), a leading provider of artificial intelligence (AI)-based big data analysis services, announced today that it will launch “Lit i...
BeiGene to Present at Cowen and Company 36th Annual Health Care Conference
Mar 01, 2016 13:00 pm UTC| Business
BEIJING, March 01, 2016 -- BeiGene, Ltd. (Nasdaq:BGNE), a clinical-stage biopharmaceutical company focused on developing molecularly-targeted and immuno-oncological drugs for the treatment of cancer, today announced...